Zhiwei Liu

3.6k total citations · 1 hit paper
100 papers, 1.8k citations indexed

About

Zhiwei Liu is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Zhiwei Liu has authored 100 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 21 papers in Epidemiology and 19 papers in Molecular Biology. Recurrent topics in Zhiwei Liu's work include Viral-associated cancers and disorders (28 papers), Polyomavirus and related diseases (10 papers) and Head and Neck Cancer Studies (9 papers). Zhiwei Liu is often cited by papers focused on Viral-associated cancers and disorders (28 papers), Polyomavirus and related diseases (10 papers) and Head and Neck Cancer Studies (9 papers). Zhiwei Liu collaborates with scholars based in China, United States and Taiwan. Zhiwei Liu's co-authors include Weimin Ye, Xiang Guo, Amirreza Naderipour, Rana Muhammad Aadil, Zulkurnain Abdul‐Malek, Ume Roobab, Alaa El‐Din A. Bekhit, Rai Naveed Arshad, Muhammad Imran Qureshi and Ming‐Huang Hong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and PLoS ONE.

In The Last Decade

Zhiwei Liu

90 papers receiving 1.7k citations

Hit Papers

Pulsed electric field: A potential alternative towards a ... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiwei Liu China 24 560 352 300 295 216 100 1.8k
Gunnar Wichmann Germany 24 538 1.0× 447 1.3× 101 0.3× 423 1.4× 200 0.9× 139 2.0k
Li Gao China 26 495 0.9× 763 2.2× 174 0.6× 548 1.9× 311 1.4× 164 2.2k
Ming‐Chih Chou Taiwan 27 319 0.6× 520 1.5× 183 0.6× 355 1.2× 297 1.4× 95 2.0k
Hidetaka Yokoe Japan 31 610 1.1× 1.5k 4.2× 136 0.5× 179 0.6× 427 2.0× 94 2.6k
Ying Wu China 23 460 0.8× 985 2.8× 140 0.5× 180 0.6× 353 1.6× 70 2.1k
Vasiliki Malamou‐Mitsi Greece 24 319 0.6× 418 1.2× 487 1.6× 453 1.5× 189 0.9× 47 1.7k
Zheng Lin China 25 152 0.3× 748 2.1× 245 0.8× 266 0.9× 298 1.4× 128 1.7k
Dong Hang China 28 759 1.4× 869 2.5× 596 2.0× 430 1.5× 576 2.7× 157 2.7k
Chien‐Chung Lin Taiwan 28 471 0.8× 758 2.2× 255 0.8× 446 1.5× 429 2.0× 116 2.3k
Horacio Astudillo‐de la Vega Mexico 34 969 1.7× 922 2.6× 352 1.2× 733 2.5× 482 2.2× 127 3.4k

Countries citing papers authored by Zhiwei Liu

Since Specialization
Citations

This map shows the geographic impact of Zhiwei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiwei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiwei Liu more than expected).

Fields of papers citing papers by Zhiwei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiwei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiwei Liu. The network helps show where Zhiwei Liu may publish in the future.

Co-authorship network of co-authors of Zhiwei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiwei Liu. A scholar is included among the top collaborators of Zhiwei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiwei Liu. Zhiwei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Cheng‐Ping, Yanhong Chen, Wan‐Lun Hsu, et al.. (2025). A Comparative Study of Epstein-Barr Virus Genomes Detected in Tumor, Nasopharyngeal Swab, and Saliva Samples From Patients With Nasopharyngeal Carcinoma. The Journal of Infectious Diseases. 232(3). 735–744. 1 indexed citations
3.
Liu, Zhiwei, Helen E. Heslop, Rayne H. Rouce, et al.. (2025). Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas. Blood Advances. 9(7). 1658–1669.
4.
Jackson, Sarah S., Julia M. Francis, Ruth M. Pfeiffer, et al.. (2025). Sex Differences in Anti–Epstein-Barr Virus Antibody Responses. The Journal of Infectious Diseases. 232(4). e671–e675. 2 indexed citations
5.
Sun, Lili, et al.. (2023). Validation of the Nottingham Hip Fracture Score in Predicting Postoperative Outcomes Following Hip Fracture Surgery. Orthopaedic Surgery. 15(4). 1096–1103. 15 indexed citations
7.
Liu, Zhiwei, Kelly J. Yu, Anna E. Coghill, et al.. (2022). Utility of Epstein–Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening Programs. Clinical Chemistry. 68(7). 953–962. 16 indexed citations
8.
Simon, Julia, Zhiwei Liu, Nicole Brenner, et al.. (2020). Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex Serology. Journal of Clinical Microbiology. 58(5). 13 indexed citations
9.
Lee, Mei–Hsuan, Yu‐Han Huang, Anna E. Coghill, et al.. (2020). Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan. The Journal of Infectious Diseases. 223(3). 441–444. 5 indexed citations
10.
Liu, Zhiwei, Andriy Derkach, Kelly J. Yu, et al.. (2020). Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer. Cancer Research. 81(4). 1148–1152. 16 indexed citations
11.
Yu, Guoqin, Anna E. Coghill, Kelly J. Yu, et al.. (2019). Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma. Scientific Reports. 9(1). 29 indexed citations
12.
Liu, Zhiwei, Kelly J. Yu, Anna E. Coghill, et al.. (2019). Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for Standardization. Journal of Clinical Microbiology. 57(11). 7 indexed citations
13.
Liu, Zhiwei, Ruth F. Jarrett, Henrik Hjalgrim, et al.. (2019). Evaluation of the antibody response to the EBV proteome in EBV‐associated classical Hodgkin lymphoma. International Journal of Cancer. 147(3). 608–618. 12 indexed citations
14.
Liu, Zhiwei, Troy J. Kemp, Yu‐Tang Gao, et al.. (2018). Association of circulating inflammation proteins and gallstone disease. Journal of Gastroenterology and Hepatology. 33(11). 1920–1924. 52 indexed citations
15.
Coghill, Anna E., Ruth M. Pfeiffer, Carla Proietti, et al.. (2018). Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clinical Cancer Research. 24(6). 1305–1314. 47 indexed citations
16.
Wilson, Katherine L., Zhiwei Liu, Jiaqi Huang, et al.. (2018). Poor oral health and risk of incident myocardial infarction: A prospective cohort study of Swedish adults, 1973–2012. Scientific Reports. 8(1). 11479–11479. 8 indexed citations
17.
Liu, Zhiwei, Troy J. Kemp, Yu-Tang Gao, et al.. (2018). Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer. Scientific Reports. 8(1). 5671–5671. 14 indexed citations
18.
Liu, Zhiwei, Parag Mahale, & Eric A. Engels. (2018). Sepsis and Risk of Cancer Among Elderly Adults in the United States. Clinical Infectious Diseases. 68(5). 717–724. 42 indexed citations
19.
Liu, Zhiwei, Ellen T. Chang, Qing Liu, et al.. (2016). Oral Hygiene and Risk of Nasopharyngeal Carcinoma—A Population-Based Case–Control Study in China. Cancer Epidemiology Biomarkers & Prevention. 25(8). 1201–1207. 38 indexed citations
20.
Ye, Yan-Fang, Yan‐Qun Xiang, Fang Fang, et al.. (2015). Hepatitis B Virus Infection and Risk of Nasopharyngeal Carcinoma in Southern China. Cancer Epidemiology Biomarkers & Prevention. 24(11). 1766–1773. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026